Literature DB >> 8786292

Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.

N J Viner1, C A Nelson, B Deck, E R Unanue.   

Abstract

We investigated the specificity of T cell hybridomas isolated from mice immunized with synthetic peptides identical in sequence with the dominant, naturally processed, I-Ak-restricted peptides of hen egg lysozyme (HEL). Surprisingly, the majority of hybridomas showed little or no recognition of intact HEL after processing by different APCs. This was not an artifact caused by the use of synthetic peptides since the peptide-specific hybridomas responded to a tryptic digest of HEL or to naturally processed HEL peptides extracted from I-Ak. Thus, the interaction of free peptides with class II MHC molecules can generate complexes that are antigenically dissimilar to those resulting from intracellular processing of intact Ag. This has important implications both for the interpretation of experimental studies that involve peptide immunization and for the efficacy of peptide vaccination as a strategy for intervention in human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786292

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

Review 2.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 4.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma.

Authors:  Eleni Tiniakou; Andrea Fava; Zsuzsanna H McMahan; Tara Guhr; Robert N O'Meally; Ami A Shah; Fredrick M Wigley; Robert N Cole; Francesco Boin; Erika Darrah
Journal:  Arthritis Rheumatol       Date:  2020-06-26       Impact factor: 10.995

6.  Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.

Authors:  J van Bergen; S P Schoenberger; F Verreck; R Amons; R Offringa; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex.

Authors:  J D Rabinowitz; K Tate; C Lee; C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro.

Authors:  Chuda Chittasupho; Joshua Sestak; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Mol Pharm       Date:  2013-12-04       Impact factor: 4.939

9.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen.

Authors:  H Drakesmith; D O'Neil; S C Schneider; M Binks; P Medd; E Sercarz; P Beverley; B Chain
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.